Successful treatment of anti ‐PTX3 positive seronegative rheumatoid arthritis with upadacitinib

AbstractSeronegative rheumatoid arthritis (SNRA) can be a rapid-progressing and highly disabling disease. Anti-PTX3 autoantibody may be a potential biomarker in SNRA diagnosis. SNRA patients could respond well to upadacitinib.

Source: International Journal of Rheumatic Diseases - September 14, 2023 Category: Rheumatology Authors: Haojie Xu, Bang Su, Rong Li, Lu Wang, Jiaxin Zhou, Lidan Zhao Tags: CASE REPORT Source Type: research